Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler. New study findings indicate that accurate inhaler ...

With a growing availability of different devices and types of medication, additional evidence is required to assist clinicians in prescribing the optimal medication in relation to chronic obstructive ...

The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA earlier this week approved sales ...

The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday approved sales of ...

You can save this article by registering for free here. Or sign-in if you have an account. TRENTON, N.J. — The Food and Drug Administration has approved the first inhaler combining three medicines to ...

NEW ORLEANS — Switching inhaler types due to insurance formulary changes may lead to reduced lung function in children with asthma, according to data presented at the CHEST Annual Meeting. “Insurance ...

Global Respiratory Inhalers Market Forecast2021-2031 (Value & Volume): - by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others ...